Serralysins are a family of metalloproteases secreted by Gram-negative bacteria into the medium in the form of inactive zymogens. Usually, all serralysin secretors have on the same operon a gene coding for a periplasmic 10-kDa protein, which is an inhibitor of the secreted protease. The recent characterization of the inhibitor of the alkaline protease from Pseudomonas aeruginosa revealed a surprisingly low dissociation constant of 4 pM, contrary to earlier studies on homologous systems, where inhibition constants in the M range were reported. To approach a more accurate understanding, the crystal structure of the complex between inhibitor and protease from P. aeruginosa was determined at 1.74 Å resolution and refined to R free ‫؍‬ 0.204. The structure reported here shows clearly that the N terminus of the inhibitor forms a coordinative bond to the catalytic Zn 2؉ ion with a nitrogen-zinc distance of 2.17 Å. We conclude that this interaction adds substantially to the complex stability and show also that similar interactions are found in other metzincin-inhibitor complexes.
Pseudomonas aeruginosa is a ubiquitous bacterium that is responsible for many nosocomial infections such as pneumonia (1) , surgical wound infections (2) , and respiratory tract infections in cystic fibrosis patients (3) . P. aeruginosa secretes a large variety of proteins (4) . One of these proteins is the alkaline protease aeruginolysin (APR), 1 originally characterized by Morihara (5, 6) .
APR is a member of the serralysin family, a group of 500-kDa bacterial metalloproteases which in turn belong to the metzincin metalloprotease superfamily (7) . The metzincins are characterized by the zinc binding motif HEXXHXXGXXH and a conserved methionine, which is located on a turn near the catalytic site, 40 -60 residues toward the C terminus. Although sequence identity 2 between the different subfamilies of the metzincins is very low, their catalytic domains do have similar three-dimensional structures (8 -14) . X-ray crystallography of APR (13) , of the Serratia marcescens homologue called SMP (Serratia metalloprotease (14) ), and of PrtC, one of four serralysins secreted by Erwinia chrysanthemi, 3 shows that serralysins can be divided into an N-terminal catalytic domain and a C-terminal structural domain, each consisting of about 230 to 240 residues. The structural domain consists of the secretion signal located within the last 70 residues and a repetitive glycine-rich nonapeptide (15) (16) (17) that folds into a ␤-roll stabilized with calcium ions. These sequence repeats have been found in a variety of toxins, the so-called RTX toxins (18) , and appear to be involved also in the secretion process.
Like other serralysin secretors, P. aeruginosa can produce a specific protease inhibitory protein of 131 residues, including a signal peptide of 25 residues that is cleaved off during secretion into the periplasm. The inhibitor is entirely located in the periplasm of P. aeruginosa, where its presumed physiological function is to protect the periplasmic proteins against the secreted protease. Until now, there are seven known members of this inhibitor family with a sequence identity of about 20% and a similarity of about 50% (Refs. 17 and 20 -23; Table I ).
Sequence identity mainly is found in the 15 N-terminal residues of the mature inhibitor. The structure of the E. chrysanthemi inhibitor has been solved by x-ray crystallography (19) . It consists of an eight-stranded ␤-barrel and an N-terminal segment of ϳ10 residues on top of the barrel. This highly conserved segment was shown to be just long enough for Ser-1I to reach the catalytic zinc ion of the protease, with the barrel body preventing further intrusion of the inhibitor into the active-site cleft. N-terminal sequence analysis revealed that Ser-1I is cleaved off to about 50%, making interpretations regarding Ser-1I more difficult.
Recent kinetic studies on the alkaline protease inhibitor of P. aeruginosa (APRin) (20) revealed a large difference in the inhibitory activity (K D of 4 pM) compared with the inhibitors of E. chrysanthemi (21) and S. marcescens (22) , which have K D values of 1-10 and 0.7 M, respectively. Detailed analysis of the kinetic data from APRin with its cognate protease APR revealed the importance of the N-terminal trunk of the inhibitor for high-affinity binding (20) .
Because of the importance of metallo-endoproteases in many diseases (e.g. cancer or arthritis) and to get a better understanding of what leads to this difference in inhibitory activity, we determined the crystal structure of the complex between P. aeruginosa alkaline protease and its cognate inhibitor (Protein Data Bank code 1JIW).
EXPERIMENTAL PROCEDURES
Protein Preparation-Wild-type APRin was expressed from the pET22b(ϩ) vector in Escherichia coli strain BL21(DE3) and purified from periplasm obtained by osmotic shock as described by Feltzer et al. (20) . The protein exhibited the expected mass by electrospray mass spectrometry. Crystalline APR was from Nagase Biochemicals, Tokyo, and was purified as described previously (20) .
Crystallization and Data Collection-Crystals were obtained by the vapor diffusion method (sitting or hanging drops) using either 20% polyethylene glycol (PEG 4000), 20% isopropanol, and 0.1 M citrate (pH 5.6) or 30% PEG 4000, 0.2 M ammonium acetate, and 0.1 M citrate (pH 5.6) at 20°C. Crystals belong to orthorhombic space groups P2 1 2 1 2 and P2 1 2 1 2 1 , respectively. The asymmetric unit of each crystal form contains one complex with a molecular mass of about 60 kDa.
A data set from a crystal grown in the buffer containing isopropanol was collected at the Swiss Norwegian beam line of the European synchrotron radiation facility in Grenoble on a MAR345 image plate at a temperature of 110 K, a distance of 270 mm, and a frame width of 0.5°. An additional data set from a crystal grown under ammonium acetate condition was collected in house on a rotating anode generator (Rigaku) with an R-Axis IV image plate. All data were processed with the HKL suite (23) . Some data collection statistics are shown in Table II .
Structure Solution and Refinement-The structure was solved using the coordinates of APR (13) (Protein Data Bank code 1KAP) as a search model. Calculations and refinement were done using the programs of CNS, version 1.0 (24) , and models were inspected with 2F o Ϫ F c and F o Ϫ F c maps using the program O (25) .
The rotation function calculated in the resolution range from 15 to 4 Å yielded one solution with a height of 4.87 above the mean; the next highest peak scored 1.60 . The translation function gave a unique solution with a correlation coefficient of 0.68 (second highest solution, 0.11). The following rigid body refinement led to a decrease of the R-factor from 0.47 to 0.38 in the resolution range from 15 to 3.5 Å. A SIGMAA-weighted 2F o Ϫ F c electron density map revealed well defined additional electron density near the active-site cleft, which was readily interpreted even without using the known E. chrysanthemi inhibitor structure (19) . Only a few regions showed no interpretable density (loops between s1 and s2, s6 and s7), and it took several rounds of rebuilding and refinement until these parts of the structure could be fitted reliably in the electron density.
The model was subjected to further refinement and was completed in the usual stepwise manner. In later stages, water molecules were inserted at stereochemically reasonable positions where the difference density had values of three above the mean and the 2F o Ϫ F c map showed density at the one level. Refinement statistics are shown in Table II .
RESULTS
Structure of the Inhibitor-The inhibitor of P. aeruginosa folds into an eight-stranded antiparallel ␤-barrel with the approximate dimensions 33 ϫ 33 ϫ 26 Å and a simple up-down topology (Fig. 1) . 
marcescens).
Sequence numbering starts with the mature inhibitor. Secondary structure elements are marked:^, helices; -, ␤-strands. A "#" denotes a polar residue, a "$" a non-polar residue. Numbering is according to the mature inhibitor.
Although the sequence similarity between the inhibitors of P. aeruginosa and E. chrysanthemi is around 50%, the x-ray structures are almost identical, including the N-terminal segment, the disulfide bridge (Cys-26I and Cys-49I), the helices hA and hB, and the hydrophobic core. The r.m.s. deviation of 97 equivalent C␣ atoms (out of 100 and 105, respectively) is about 1.4 Å. Differences occur in the loops between the ␤-strands and usually derive from additional amino acids in the P. aeruginosa inhibitor; the loop connecting ␤-strands s1 and s2 is enlarged by two residues, the loops between s2 and s3 and between s6 and s7 are enlarged by one residue each, and there is one additional residue at the C terminus.
A comparison between the structures of the two crystal forms shows no major differences despite very different packing; the r.m.s. deviation of all C␣ atoms is 0.45 Å, which is approximately within the error limits. Especially notable is that all segments of APRin interacting with the protease, including the N-terminal trunk, exhibit identical conformations.
Interaction with the Alkaline Protease-A total of 118 contacts within 3.8 Å between APR and APRin are found in this complex. APRin contacts the protease mainly via its N-terminal trunk (residues 1I-5I), the type IV ␤-turn connecting ␤-strands s4 and s5 (comprising residues 62I-66I) and the loop 81I-85I. Further interaction sites are residues 71I, 74I, and 36I, which are located in loops on the barrel bottom according to the orientation shown in Fig. 1 .
On the side of the protease residues from the edge strand (134P-136P), the active-site tyrosine 218P and the flexible loop closing the active-site cleft (residues 188P-192P) are in close contact with the inhibitor. Further interactions involve Tyr-169P and the segment 225P-227P. Table III shows an interaction matrix between protease and inhibitor.
The five N-terminal residues of APRin bind in an extended conformation along the active-site cleft (Fig. 2, A and B) . The twist of the N-terminal segment that was observed in the E. chrysanthemi inhibitor occurs in APRin as well. The twist is probably not a feature of the free inhibitor, where the N-terminal segment is flexible, 4 but rather is imposed by the binding to the protease. This strong twist of the N-terminal segment leads to a binding mode presumably slightly different from substrates, which most likely bind as antiparallel ␤-strands to the edge strand of the protease, employing full hydrogen bonding of the backbone.
One of the most conspicuous features is the close contact of the N-terminal amino group of Ser-1I of the inhibitor and the catalytic zinc ion. Ser-1I occupies a position roughly between the P1 and P1Ј residues of a true substrate. In the case of the 
TABLE III

Contact matrix
Inhibitor residues are in rows, protease residues in columns. Hydrogen bonds are denoted in parentheses.
E. chrysanthemi inhibitor-S. marcescens protease complex, this residue was partially cleaved off leading to some difficulties in the interpretation regarding its interactions with the zinc ion. In the structure reported here, no proteolytic cleavage has taken place and the electron density map is unambiguous (Fig. 2A) .
The distances between the carbonyl oxygen and the N-terminal amino group of Ser-1I and the zinc ion are only 2.22 and 2.19 Å, respectively, and hence are in the range of a coordinative bond. For comparison, the distances between N⑀2 of the histidine ligands and the Zn 2ϩ are 2.09, 2.16, and 2.03 Å. The N terminus replaces the catalytically active water molecule that is normally bound to the zinc ion. This structural feature might not only provoke the twist at the N-terminal trunk but might also be responsible for the observed decrease of K D to about 4 pM compared with the E. chrysanthemi and S. marcescens complexes for which dissociation constants in the 0.1 to 1 micromolar range have been reported (21, 22) .
The conserved Ser-2I donates a hydrogen bond to Glu-177P, the catalytic base of the HEXXH motif, similar to the one observed in the E. chrysanthemi inhibitor complex. Also, the main-chain hydrogen bond between the carbonyl oxygen of Ser-2I and the backbone amide nitrogen of residue Ala-134P is present in this complex.
Further interactions occur between the barrel body of the inhibitor (s5, s6, and s7) and the irregular loop 218P-229P of the protease. Analysis of the interface shows that 1990 Å 2 of solvent-accessible surface become buried upon complex formation, a result very comparable with the one obtained in the case of the Inh⅐SMP complex. To evaluate further the differences in binding of APRin to APR compared with Inh⅐SMP, a geometrical shape complementarity analysis was carried out using the program SC (26) as implemented in the CCP4 package (27) . The correlation coefficient in the Inh⅐SMP complex was calculated to be 0.67 compared with 0.73 in the case of APRin⅐APR, a small but significant increase. This analysis also shows that the water-filled cavity reported to exist between inhibitor barrel and protease in the Inh⅐SMP complex is also present in the APRin⅐APR structure, although considerably reduced in size from 185 to 65 Å 3 .
DISCUSSION
This high-resolution structure of the APR⅐APRin complex reveals clearly the presence of a coordinative interaction between the N terminus of the inhibitor and the catalytic zinc ion. For this, the N-terminal amino group, which has a pK a ϳ 8, has to be deprotonated first. This proton could be transferred to a water molecule or to Glu-177P. It is reasonable to assume that the pK a of the amino terminus becomes significantly lower upon interaction with the zinc ion.
Interestingly, similar interactions have been observed between matrix metalloproteases and their cognate inhibitors TIMP-1 and TIMP-2 (28, 29) Fig. 3 shows the structure of the complex between TIMP-2 and MT-1 (29) (Protein Data Bank code 1BUV). The binding mode, including the N-terminal coordination of the zinc and the hydrogen bonds between Ser-2I and the protease, is absolutely conserved despite the lack of any homology between the two inhibitors. This confirms an earlier hypothesis that proteinaceous metzincin inhibitors show similar inhibition modes. The small serralysin inhibitors, however, lack the interactions present in the TIMP complexes with the S-sites of the protease (28) .
However, although the binding of the inhibitors is similar, specificity between TIMP and serralysin inhibitors is different. For example, APRin neither inhibits collagenase, gelatinase A, or gelatinase B (20) nor has it been reported that TIMPs inhibit serralysins. The lack of inhibition arises from the different surfaces on the inhibitor body and the proteases. The length of the N-terminal trunk is precisely such that the amino group reaches the zinc ion and the N-terminal residue chelates the zinc via the NH 2 group and the carbonyl oxygen. The ␤-barrel body of the inhibitor prevents the N-terminal trunk from being drawn further into the active-site cleft and subsequent proteolysis.
On the other hand, the serralysin inhibitors cross-react at least to some extent with the various serralysins. This can be explained by the fact that most interactions occur within the rather conserved N-terminal trunk of the inhibitor and the SЈ-sites of the protease whereby there is a lack of side chainside chain interaction and hence of sequence specificity. Sitedirected mutagenesis experiments (20) show that removal of the first two amino acids produces some 5000-fold reduction in affinity, whereas removal of the N-terminal six amino acids leads to a complete loss of inhibitory activity. The interaction between Tyr-216P, the putative electrophile stabilizing the tetrahedral intermediate in catalysis, and Ser-1I seems to be of minor importance because mutation of Ser-1I to Gly gives an even somewhat lower dissociation constant.
Overlay of the APR⅐APRin structure on the Inh⅐SMP complex shows some clashes occurring between the barrel body of the inhibitor and the non-cognate protease SMP, which would probably lead to a higher dissociation constant; however, the N-terminal trunks overlay very well.
An unsolved problem is the explanation of the vastly differing inhibition constants reported for various serralysin inhibitors. One reason could be that some studies have paid only slight attention to the presence of an intact mature N terminus. In the case of the Serratia inhibitor, original expression studies in S. marcescens led to a product in which the N terminus was shortened by three amino acids (22) .
Interestingly, despite the high conservation of the N-terminal region, studies on the S. marcescens inhibitor SmaPI found virtually no influence from the first two amino acids, or even from the addition of an extra amino acid to the N-terminus, but a very strong contribution from Leu-3I (ϳ0.7 kcal/mol) (30), a residue conserved in all serralysin inhibitors (Table I) . Contrary to this finding, Feltzer et al. (20) found that Leu-3I contributes only approximately as much as Ser-2I and Ser-1I together. Leu-3I fits nicely into a pocket formed by residues Tyr-216P, Trp-217P, Tyr-169P, and Ala-192P of the protease and the turn 64I-67I of the inhibitor. We cannot explain the differences found in that study using our model, but those authors used a para-nitroanilide substrate, which does not occupy significantly the SЈ-sites of the protease but rather the S-sites, whereas the APRin binds to the SЈsites exclusively. We also cannot exclude the possibility that some "fraying" of the N terminus occurred because of proteolytic cleavage in that study. Such proteolytic processing has been described for SmpI (22) and also in the Inh⅐SMP structure (19) .
The same study (30) also concluded that there is a significant conformational rearrangement of the protease and/or inhibitor upon complex formation. However, with the exception of two segments, there are no significant differences observable comparing the crystal structures of the alkaline protease in complex with a peptide that occupies the S-sites (13) and in the complex with the inhibitor, the latter one occupying the SЈ-sites of the protease. In accordance with this finding, no significant differences were detected between the fluorescence spectra of the APRin⅐APR complex and the individual components (20) . The r.m.s. deviations for all C␣ atoms of the protease is about 0.58 Å (Fig. 4) . The exceptions are the flexible loops 48P-52P and 188P-192P of the protease. The latter is the active-site loop and, interestingly, adopts a slightly different conformation, which may originate from the contacts between segment 83I-88I of the inhibitor.
Taking the results of this study and of the Inh⅐SMP structure, it seems rather unlikely that major conformational rearrangements, either on the inhibitor or the protease side, will take place upon complex formation.
A preliminary modeling of APRin complexes with other serralysins, e.g. S. marcescens protease or protease C from E. chrysanthemi, shows a satisfactory fit with a few clashes between the barrel bodies of the inhibitor and the protease. The main interactions between the N-terminal trunk and protease seem to be conserved, which explains the cross-reactivity.
